Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps.

J Biol Chem 2017 08 6;292(32):13284-13295. Epub 2017 Jun 6.

the Gladstone Institute of Virology and Immunology, San Francisco, California 94158

Lytic infection by the Epstein-Barr virus (EBV) poses numerous health risks, such as infectious mononucleosis and lymphoproliferative disorder. Proteins in the bromodomain and extraterminal (BET) family regulate multiple stages of viral life cycles and provide promising intervention targets. Synthetic small molecules can bind to the bromodomains and disrupt function by preventing recognition of acetylated lysine substrates. We demonstrate that JQ1 and other BET inhibitors block two different steps in the sequential cascade of the EBV lytic cycle. BET inhibitors prevent expression of the viral immediate-early protein BZLF1. JQ1 alters transcription of genes controlled by the host protein BACH1, and BACH1 knockdown reduces BZLF1 expression. BET proteins also localize to the lytic origin of replication (OriLyt) genetic elements, and BET inhibitors prevent viral late gene expression. There JQ1 reduces BRD4 recruitment during reactivation to preclude replication initiation. This represents a rarely observed dual mode of action for drugs.

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M116.751644
Publisher Site
http://dx.doi.org/10.1074/jbc.M116.751644DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555189PMC
August 2017
33 Reads

Publication Analysis

Top Keywords

bet inhibitors
12
epstein-barr virus
8
lytic cycle
8
inhibitors block
8
bromodomain extraterminal
8
inhibitors prevent
8
bet
5
protein bzlf1
4
immediate-early protein
4
prevent expression
4
viral immediate-early
4
expression viral
4
alters transcription
4
controlled host
4
host protein
4
protein bach1
4
genes controlled
4
transcription genes
4
jq1 alters
4
cycle bet
4

References

(Supplied by CrossRef)

Similar Publications